Illinois Municipal Retirement Fund’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-39,987
Closed -$212K 1247
2025
Q2
$212K Sell
39,987
-7,279
-15% -$43K ﹤0.01% 1228
2025
Q1
$419K Sell
47,266
-7,057
-13% -$84.8K 0.01% 1246
2024
Q4
$745K Buy
54,323
+3,706
+7% +$68.4K 0.01% 1083
2024
Q3
$1.39M Buy
50,617
+3,792
+8% +$103K 0.02% 778
2024
Q2
$1.15M Buy
+46,825
New +$1.03M 0.02% 824

Other funds holding MYGN

Illinois Municipal Retirement Fund's MYGN Position: Q3 2025 in Review

Illinois Municipal Retirement Fund sold out of Myriad Genetics (MYGN) in Q3 2025, closing a stake of 39,987 shares — an estimated $212K sold.

Illinois Municipal Retirement Fund first reported a position in MYGN in Q2 2024 and held it in 5 quarters. The position peaked at $1.39M in Q3 2024. 221 funds tracked by Wall St. Rank hold MYGN as of Q3 2025.

  • Illinois Municipal Retirement Fund reported no remaining Myriad Genetics position as of Q3 2025 after selling out during the quarter.
  • Illinois Municipal Retirement Fund sold 39,987 Myriad Genetics shares in Q3 2025, an estimated $212K.
  • Illinois Municipal Retirement Fund first reported a position in Myriad Genetics in Q2 2024 and held it in 5 quarters.
  • Illinois Municipal Retirement Fund's Myriad Genetics position peaked at $1.39M in Q3 2024.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q3 2025.

Based on Illinois Municipal Retirement Fund's 13F filing for Q3 2025, filed 6 Nov 2025.